{
    "nctId": "NCT01703585",
    "briefTitle": "Feasibility Study of Genomic Profiling Methods and Timing in Tumor Samples",
    "officialTitle": "A Feasibility Study of Genomic Profiling Methods and Timing of Sample Collection to Evaluate Clonal Evolution and Tumor Heterogeneity",
    "overallStatus": "COMPLETED",
    "conditions": "Colorectal Cancer, Breast Cancer, Gynecological Cancer, Metastatic, Eligible for Phase I or Phase II Study, Melanoma Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 45,
    "primaryOutcomeMeasure": "Patient recruitment for paired core and fine needle biopsy greater than or equal to 50% of those screened or approached.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Age \u2265 18 years.\n* Histological or cytological proof of either metastatic breast, colorectal, gynecological or melanoma malignancy.\n* At least one biopsiable lesion deemed medically accessible and safe to biopsy.\n* Candidate for one or more phase I or II clinical trials at the time of study enrollment or at a later time point.\n* Fulfills local institution's laboratory parameters for tumor biopsy.\n* Willingness and ability of patient to provide signed voluntary informed consent.\n\nExclusion Criteria:\n\n* Any condition that could interfere with a patient's ability to provide informed consent such as dementia or severe cognitive impairment.\n* Any contraindication to undergoing a biopsy procedure.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}